Simulations Plus News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.02.23	Simulations Plus and Global Agrochemicals Leader to Collaborate on Machine Learning Models (Businesswire)
09.02.23	Simulations Plus Releases Redesigned NAFLDsym® QSP Software Tool (Businesswire)
12.01.23	Simulations Plus Releases DILIsym X (DSX) Beta with Redesigned Software Infrastructure (Businesswire)
12.01.23	Simulations Plus Executes $20 Million Accelerated Share Repurchase Agreement (Businesswire)
05.01.23	Pre-market Movers: OBLG, HKD, NUWE, RNER, ARCK… (RTTNews)
04.01.23	Simulations Plus Reports First Quarter Fiscal 2023 Financial Results (Businesswire)
19.12.22	Simulations Plus Sets Date for First Quarter Fiscal Year 2023 Earnings Release and Conference Call (Businesswire)
15.11.22	Simulations Plus and the University of Bath Awarded New FDA Grant (Businesswire)
10.11.22	Gustavo Mendes Lima Santos Joins the Simulations Plus Regulatory Fellowship Program (Businesswire)
03.11.22	Simulations Plus 25th Anniversary Celebration Concludes with $25,000 Gift to Nonprofit, Girls Who Code (Businesswire)
02.11.22	Simulations Plus and the University of Florida Awarded New FDA Contract to Support Development and Regulatory Assessment of Inhaled Products (Businesswire)
20.10.22	Simulations Plus Announces Cash Dividend (Businesswire)
12.10.22	Simulations Plus Releases GastroPlus® Version 9.8.3 (Businesswire)
11.10.22	Simulations Plus Sets Date for Fourth Quarter and Fiscal Year 2022 Earnings Release and Conference Call (Businesswire)
14.09.22	Simulations Plus to Present at Sidoti Fall Small Cap Investor Conference (Businesswire)
07.09.22	Simulations Plus to Present at Baird 2022 Global Healthcare Conference (Businesswire)
31.08.22	Simulations Plus Releases State-of-the-Art QSP Software for Interstitial Lung Disease (Businesswire)
04.08.22	Simulations Plus Enters New Collaboration to Enhance Machine Learning Models for Ionization Constants (pKa) (Businesswire)
26.07.22	Simulations Plus Presented New Scientific Developments at PAGE 2022 (Businesswire)
21.07.22	Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit International Organization for Childhood Cancer (Businesswire)
14.07.22	Simulations Plus Realizes Early Success with its Concierge Program (Businesswire)
06.07.22	Simulations Plus Reports Third Quarter Fiscal 2022 Financial Results (Businesswire)
30.06.22	Simulations Plus Hosts 2nd Annual Pharmacometrics Workshop (Businesswire)
23.06.22	Simulations Plus Collaborates with Multinational Pharmaceutical Company to Provide Modeling & Simulation Support for COVID-19 Treatment (Businesswire)
21.06.22	Simulations Plus Sets Date for Third Quarter Fiscal Year 2022 Earnings Release and Conference Call (Businesswire)
26.05.22	Simulations Plus Releases ADMET Predictor Version 10.4 (X.4) (Businesswire)
05.05.22	U.S. FDA Renews Annual DILIsym Software Licenses for 2022 (Businesswire)
28.04.22	Simulations Plus Successfully Delivers FDA-Funded Project (Businesswire)
21.04.22	Simulations Plus Enters New Collaboration to Advance DDDPlus™ Software (Businesswire)
19.04.22	Simulations Plus to Present at the Berenberg Discover AI Seminar (Businesswire)
29.03.22	Simulations Plus Receives $1.7 Million Grant for BIOLOGXsym™ Macromolecule Safety Software (Businesswire)
24.03.22	Simulations Plus Hosts the 2022 Model-Informed Drug Development (MIDD+) Scientific Conference (Businesswire)
22.03.22	Simulations Plus Sets Date for Second Quarter Fiscal Year 2022 Earnings Release and Conference Call (Businesswire)
17.03.22	Simulations Plus Celebrates 25-Year Anniversary with $25,000 Gift to Nonprofit National Organization for Rare Disorders (Businesswire)
10.03.22	Simulations Plus Releases MembranePlus 3.0 (Businesswire)
08.03.22	Simulations Plus to Present at Oppenheimer Annual Healthcare Conference (Businesswire)
02.03.22	Simulations Plus to Present at Raymond James Institutional Investors Conference (Businesswire)
08.02.22	Simulations Plus to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Businesswire)
20.01.22	Simulations Plus Partners with Large Pharmaceutical Company to Drive Advancements to the GastroPlus Mechanistic Oral Absorption Model (Businesswire)
13.01.22	Simulations Plus Enters New Collaboration with Leading Animal Health Company (Businesswire)
12.01.22	Simulations Plus to Present at Sidoti Winter Small Cap Investor Conference (Businesswire)
06.01.22	Simulations Plus Reports First Quarter Fiscal 2022 Financial Results (Businesswire)
05.01.22	Lixoft Adds New Bioequivalence Module in MonolixSuite® Version 2021R1 (Businesswire)
20.12.21	Simulations Plus Sets Date for First Quarter Fiscal Year 2022 Earnings Release and Conference Call (Businesswire)
30.11.21	Simulations Plus celebrates 25-year anniversary with $25,000 gift to nonprofit Dispensary of Hope (PR Newswire)
08.07.21	Simulations Plus Celebrates 25 Years in Business (Businesswire)
28.06.21	Simulations Plus Sets Date for Third Quarter Fiscal Year 2021 Earnings Release and Conference Call (Businesswire)
17.06.21	Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantitative Systems Pharmacology (QSP) Software for Idiopathic Pulmonary Fibrosis (IPF) (Businesswire)
27.05.21	Simulations Plus to Participate in 18th Annual Craig-Hallum Institutional Investor Conference (Businesswire)
13.05.21	Simulations Plus to Present at 16th Annual Needham Virtual Technology & Media Conference (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	137.35	1.40 %	K V
Sonova Hldg	297.30	1.29 %	K V
Logitech Intl	74.86	1.22 %	K V
Nestle	75.22	1.02 %	K V
Alcon	76.32	0.95 %	K V
UBS Group	28.17	-0.67 %	K V
Swiss Re	131.95	-0.68 %	K V
Geberit	533.80	-0.78 %	K V
Lonza Grp	541.40	-0.81 %	K V
Kuehne+Nagel Int	202.60	-1.65 %	K V

Nachrichten zu Simulations Plus IncShs

Aktien Top/Flop

Meistgelesene Nachrichten